Imatinib Mesylate

Definition

Imatinib mesylate is an enzyme inhibitor used for cancer therapy. Imatinib mesylate is also known as STI571 and is sold under the brand name, Gleevec. It was given the name STI571 during early development. STI stands for signal transduction inhibitor.

Purpose

Imatinib mesylate is approved by the U. S. Food and Drug Administration to treat a rare cancer called chronic myeloid leukemia (CML). (CML is also called chronic myelogenous leukemia or chronic myelocytic leukemia, as well.)

Description

Imatinib mesylate is the first drug of its kind developed. It fights cancer by turning off an enzyme called...

[The entire page is 1087 words long]

Join eNotes

The above is a free excerpt. Get total access to this content with the: